fluorodeoxyglucose f18 has been researched along with nimodipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heiss, WD; Holthoff, V; Neveling, M; Pawlik, G | 1 |
| Ito, K; Kato, T | 1 |
1 review(s) available for fluorodeoxyglucose f18 and nimodipine
| Article | Year |
|---|---|
[Positron emission tomography: contribution to diagnosis of dementia and development of disease-modifying drugs].
Topics: Alzheimer Disease; Amyloid; Clinical Trials as Topic; Cohort Studies; Drug Discovery; Early Diagnosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Nimodipine; Nootropic Agents; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
1 trial(s) available for fluorodeoxyglucose f18 and nimodipine
| Article | Year |
|---|---|
Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischemic stroke as measured by positron emission tomography.
Topics: Acute Disease; Brain; Brain Ischemia; Cerebrovascular Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nimodipine; Tissue Distribution; Tomography, Emission-Computed | 1990 |